Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04432753 · ClinicalTrials.gov registry record · NA
Effect of Incidental Findings Information on Lung Cancer Screening Intent
A NA study, sponsored by UNC Lineberger Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 419
- Enrollment target
NCT04432753: Completed NA study, sponsored by UNC Lineberger Comprehensive Cancer Center.
NCT04432753 is a NA study that has completed, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 419 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (70% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04432753, a NA study, has completed, sponsored by UNC Lineberger Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 419 participants
- Enrollment target
Study Summary
This online randomized controlled trial seeks to determine if inclusion of incidental findings information in a lung cancer screening decision aid affects screening intent among screening-eligible individuals. Participants will view either a decision aid with incidental findings information or without and indicate their intent to pursue lung cancer screening. Hypothesis: Inclusion of incidental findings in a decision aid will decrease intent to screen among participants.
Primary Outcome
This will be assessed by a survey item where participants indicate their response to a statement of whether they plan to pursue lung cancer screening, with answer choices being strongly agree, agree, disagree and strongly disagree. Comparison between the intervention and control groups will be made.
Interventions
- BEHAVIORAL Lung Cancer Screening Decision Aid with Incidental Findings Information
- BEHAVIORAL Lung Cancer Screening Decision Aid without Incidental Findings Information
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 419 participants |
| Start Date | 2020-07-16 |
| Est. Completion | 2020-08-22 |
| Phase | NA |
What the finished NCT04432753 record still lists
NCT04432753 is an interventional study that assigns participants to a tested intervention. The registered 419 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (70% lower).
The record links to 0 conditions, and to 2 interventions - of which Lung Cancer Screening Decision Aid with Incidental Findings Information is the first listed.
NCT04432753 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04432753 about?
NCT04432753 is a clinical study titled "Effect of Incidental Findings Information on Lung Cancer Screening Intent". This online randomized controlled trial seeks to determine if inclusion of incidental findings information in a lung cancer screening decision aid affects screening intent among screening-eligible individuals. Participants will view either a decision aid with incidental findings information or witho...
What is the current status of trial NCT04432753?
This trial is currently completed. It is a NA study. The enrollment target is 419 participants. The study started on 2020-07-16. Estimated completion is 2020-08-22.
What interventions are being tested in trial NCT04432753?
The interventions under investigation include: Lung Cancer Screening Decision Aid with Incidental Findings Information (BEHAVIORAL), Lung Cancer Screening Decision Aid without Incidental Findings Information (BEHAVIORAL).
Who is sponsoring clinical trial NCT04432753?
This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04432753's enrollment target sits among peer trials
419 240th of 2000 higher than 1,761 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05579639 · 419 participants · Phase 2
Xylitol BSI Multisite - Reduction of Bloodstream Infections From Oral Organisms in Pediatric Stem Cell Transplant
- NCT01790152 · 420 participants
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- NCT02701244 · 420 participants
A Registry Study of Breast Microseed Treatment
- NCT02966665 · 420 participants · Phase 1
: Vascular Function in Health and Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI